Page last updated: 2024-09-03

nifekalant hydrochloride and Abnormality, Heart

nifekalant hydrochloride has been researched along with Abnormality, Heart in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chinushi, M; Furushima, H; Izumi, D; Sato, A	1

Other Studies

1 other study(ies) available for nifekalant hydrochloride and Abnormality, Heart

Article	Year
Nifekalant enlarged the transmural activation-recovery interval difference as well as the peak-to-end interval on surface ECG in a patient with short-QT syndrome. Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:8 Topics: Action Potentials; Adolescent; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fatal Outcome; Female; Heart Conduction System; Heart Defects, Congenital; Heart Rate; Humans; Predictive Value of Tests; Pyrimidinones; Time Factors; Treatment Outcome	2012

Article

Year

Nifekalant enlarged the transmural activation-recovery interval difference as well as the peak-to-end interval on surface ECG in a patient with short-QT syndrome.

Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:8

Topics: Action Potentials; Adolescent; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fatal Outcome; Female; Heart Conduction System; Heart Defects, Congenital; Heart Rate; Humans; Predictive Value of Tests; Pyrimidinones; Time Factors; Treatment Outcome

2012